IL18 and neoplasm: For example, in GKO mice, while bLF administration did not activate the IFN-γ/caspase-1/IL-18 effector pathway, it inhibited tumor growth and metastasis by activating the IFN-alpha/IL-7 effector pathway (Iigo et al., 2009).